Text Size
     
Follow us on
 
 
 
Investor Relations
 
DISCLOSURE
Disclosure Requirements as per Clause 54 of the Listing Agreement 
Bafna Pharma
A snapshot of the Company
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Financial Information
Annual reports
Quarterly results
Shareholding Pattern
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Corporate Governance Report
 
Quarterly Compliance Reports
       
click here to download click here to download click here to download click here to download
Dec 2011 Sep 2011 June 2011 March 2011
 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Contact Information for Investor Relations

K. Premnatha
Company Secretary
No.299, Thambu Chetty Street
Chennai – 600 001
Tel: 044 – 42677555
Fax: 044- 42677599
Email: cs@bafnapharma.com

 
News at Bafna
Awards
View Gallery